home / stock / jspr / jspr news


JSPR News and Press, Jasper Therapeutics Inc. From 12/02/25

Stock Information

Company Name: Jasper Therapeutics Inc.
Stock Symbol: JSPR
Market: NASDAQ
Website: jaspertherapeutics.com

Menu

JSPR JSPR Quote JSPR Short JSPR News JSPR Articles JSPR Message Board
Get JSPR Alerts

News, Short Squeeze, Breakout and More Instantly...

JSPR - AI INFRASTRUCTURE SURGE MEETS BIOTECH BUZZ

2025-12-02 07:16:45 ET DENVER, Colo., Dec 02, 2025 ( 247marketnews.com )- Markets open today with a mix of AI-driven exuberance, biotech anticipation, and selective small-cap momentum as investors digest a heavy slate of company-specific catalysts heading into the first full week of Dec...

JSPR - Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation

Reductions in airway hyperresponsiveness and suppressed eosinophilic response at both 6 weeks and 12 weeks observed after a single 180mg dose of Briquilimab in the ETESIAN Study Preliminary data from ETESIAN study supports further development of briquilimab in asthma Jasper also a...

JSPR - Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation

REDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper or the Company), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chr...

JSPR - Jasper Therapeutics GAAP EPS of -$1.13 beats by $0.08

2025-11-10 08:28:37 ET More on Jasper Therapeutics Seeking Alpha’s Quant Rating on Jasper Therapeutics Historical earnings data for Jasper Therapeutics Financial information for Jasper Therapeutics Read the full article on Seeking Alpha For fur...

JSPR - Jasper Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneou...

JSPR - JSPR Deadline: Rosen Law Firm Urges Jasper Therapeutics, Inc. (NASDAQ: JSPR) Stockholders to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, reminds investors there is a class action lawsuit on behalf of purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR), between November 30, 2023 and July 3, 2025. Jasper is a clinical-stage biotechnology company. For more inform...

JSPR - SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Jasper Therapeutics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Jasper To Contact Him Directly To Discuss Their Options If you suffered losses in Jasper and would like to discuss your legal rights, call F...

JSPR - Expected US Company Earnings on Thursday, November 6th, 2025

Avidity Biosciences Inc. (RNA) is expected to report $-1.05 for Q3 2025 Universal Electronics Inc. (UEIC) is expected to report $-0.15 for Q3 2025 Intercorp Financial Services Inc. (IFS) is expected to report $1.15 for Q3 2025 Clear Secure Inc. Class A (YOU) is expected to report $0.2...

JSPR - SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Jasper To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Jasper between November 30, 2023 and July 3, ...

JSPR - JSPR SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Jasper To Contact Him Directly To Discuss Their Options If you suffered losses in Jasper between November 30, 2023 and July 3, 2025 and would like to discuss your...

Previous 10 Next 10